Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020, registering a CAGR of 10.3% from 2014 to 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market.
The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.
Key players operating in the global bio implants market focus on product launch, and continual R&D on variants of bio implants in order to retain competitive advantage. These players also adopt inorganic growth strategy to augment geographical diversification. Few of such companies mentioned in the report are Stryker Corporation, Dentsply international, Ethicon Inc., Wright Medical Group, DePuy Synthes, Biomet (Zimmer), Smith & Nephew, KLS martin and Medtronic.
Key Market Segments
Market by Product Types
Market by Geography